Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q96CA5
UPID:
BIRC7_HUMAN
Alternative names:
Kidney inhibitor of apoptosis protein; Livin; Melanoma inhibitor of apoptosis protein; RING finger protein 50; RING-type E3 ubiquitin transferase BIRC7
Alternative UPACC:
Q96CA5; Q9BQV0; Q9H2A8; Q9HAP7
Background:
Baculoviral IAP repeat-containing protein 7 (BIRC7), also known as Livin, plays a pivotal role in apoptosis regulation, cell proliferation, and cell cycle control. It exhibits both proapoptotic and anti-apoptotic activities, mediated through the inhibition of caspases and its E3 ubiquitin-protein ligase activity. BIRC7's ability to ubiquitinate DIABLO/SMAC, targeting it for degradation, underscores its significance in promoting cell survival.
Therapeutic significance:
Understanding the role of Baculoviral IAP repeat-containing protein 7 could open doors to potential therapeutic strategies. Its involvement in apoptosis and cell cycle control makes it a promising target for cancer therapy, offering avenues for the development of novel treatments that manipulate cell death pathways.